Does ECULIZUMAB Cause Therapy non-responder? 101 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 101 reports of Therapy non-responder have been filed in association with ECULIZUMAB (SOLIRIS). This represents 0.2% of all adverse event reports for ECULIZUMAB.
101
Reports of Therapy non-responder with ECULIZUMAB
0.2%
of all ECULIZUMAB reports
7
Deaths
18
Hospitalizations
How Dangerous Is Therapy non-responder From ECULIZUMAB?
Of the 101 reports, 7 (6.9%) resulted in death, 18 (17.8%) required hospitalization, and 3 (3.0%) were considered life-threatening.
Is Therapy non-responder Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ECULIZUMAB. However, 101 reports have been filed with the FAERS database.
What Other Side Effects Does ECULIZUMAB Cause?
Fatigue (4,858)
Off label use (4,228)
Haemoglobin decreased (3,028)
Headache (2,699)
Death (2,221)
Pyrexia (1,948)
Dyspnoea (1,819)
Asthenia (1,732)
Drug ineffective (1,644)
Nausea (1,579)
What Other Drugs Cause Therapy non-responder?
ETANERCEPT (3,472)
APREMILAST (3,360)
METHOTREXATE (2,965)
RITUXIMAB (2,731)
ADALIMUMAB (2,595)
PREDNISONE (2,563)
TREPROSTINIL (2,289)
INFLIXIMAB (2,122)
TOCILIZUMAB (1,775)
HYDROXYCHLOROQUINE (1,699)
Which ECULIZUMAB Alternatives Have Lower Therapy non-responder Risk?
ECULIZUMAB vs EDARAVONE
ECULIZUMAB vs EDETATE
ECULIZUMAB vs EDOXABAN
ECULIZUMAB vs EDOXABAN TOSILATE
ECULIZUMAB vs EFALIZUMAB